Skip to main content
. 2010 Jul 28;92(4):741–747. doi: 10.3945/ajcn.2010.29475

TABLE 2.

Characteristics of children enrolled into the follow-up study whose mothers participated in a trial of calcium supplementation during pregnancy1

Placebo
Supplement
Males (n = 88) Females (n = 83) Males (n = 87) Females (n = 93)
Age (y) 7.4 ± 1.2 7.3 ± 1.2 7.5 ± 1.2 7.3 ± 1.2
Systolic BP (mm Hg) 97.0 ± 8.1 99.3 ± 9.0 98.1 ± 8.1 97.9 ± 8.7 [92]
Diastolic BP (mm Hg) 57.1 ± 7.2 58.7 ± 7.1 57.3 ± 7.5 58.6 ± 7.8 [92]
Pulse pressure (mm Hg)2 39.9 ± 6.4 40.6 ± 6.1 40.9 ± 6.8 39.3 ± 5.8 [92]
MAP (mm Hg)3 70.4 ± 6.9 72.2 ± 7.3 70.9 ± 7.0 71.7 ± 7.6 [92]
Height (cm) 118.3 ± 7.8 118.8 ± 8.7 118.4 ± 7.4 117.3 ± 7.9
HAZ4 −1.13 ± 0.77 −0.81 ± 1.02 −1.18 ± 0.84 −1.12 ± 0.75
Weight (kg) 19.6 ± 2.8 20.0 ± 4.1 20.1 ± 3.4 19.1 ± 3.2
BMI (kg/m2) 14.0 ± 0.9 14.0 ± 1.2 14.3 ± 1.1 13.8 ± 1.2
FMI (kg/m1.6) 1.88 ± 0.38 [85] 2.51 ± 0.62 [81] 2.01 ± 0.49 [86] 2.39 ± 0.55 [92]
LMI (kg/m2.3)3 11.59 ± 0.77 [85] 11.12 ± 0.73 [81] 11.76 ± 0.80 [86] 11.02 ± 0.82 [92]
Trunk fat (%)5 13.4 ± 2.5 [85] 14.4 ± 3.0 [81] 13.8 ± 2.9 [86] 14.1 ± 2.7 [92]
1

Values are means ± SDs; placebo and supplement refer to maternal intervention. Numbers in brackets reflect subject numbers that differ from those indicated in the column headings. MAP, mean arterial pressure; HAZ, height-for-age z score; FMI, fat mass index; LMI, lean mass index; BP, blood pressure.

2

Calculated as systolic – diastolic blood pressure.

3

MAP calculated as diastolic + (1/3 × pulse pressure).

4

Estimated from UK 1990 reference data (26).

5

Estimated by the Tanita inbuilt equations, not from population-specific equations.

HHS Vulnerability Disclosure